Twelve weeks of supplementation with hyaluronan – also known as hyaluronic acid – may improve the “luster” of the skin and reduce wrinkles, says a new study from Japan.
New gut-mediated therapies could be on the horizon, according to new research that finds GPCR (G-protein-coupled receptor) ligands, formed by gut bacteria, mimic human signalling molecules.
As the “one-size-fits-all” nutritional model becomes less relevant, consumer interest in personalized nutrition and ‘taking back control’ is growing, but the past 15 years are littered with harsh lessons. So, why are today’s companies better positioned...
A combination of four probiotic strains may shorten the duration of an infection with Clostridium difficile, says a new study that supports the role of probiotics to counter the most common cause of hospital-acquired infections.
Manufacturers and distributors of very low calorie diet (VLCD) programmes and products could be effectively wiped out by new rules passed by European lawmakers last week, warn industry leaders.
When it comes to maintaining muscle mass and fighting the risk of frailty, it’s not just about how much protein you get but how often you get it, new research suggests.
Israeli lipids ingredients specialist Enzymotec has acquired an American supplement developer in a move to revitalize its stumbling medical foods subsidiary that has run into regulatory difficulties in the United States.
Combining the probiotic Lactobacillus reuteri with the protein tryptophan could help promote greater ‘tolerance’ in immune cells in the gut, according to new animal data.
Omega-3 deficiency and heightened inflammation are associated with prenatal depression (PND), with the former resulting in longer depressive episodes, according to a recent Taiwanese study.
A signalling molecule produced by the the omega-3 fatty acid DHA could be used to target age-related conditions and diseases including stroke and Alzheimer’s, new research suggests.
The European Commission (EC) has conditionally cleared a two-way deal acquisition between FMC and DuPont, based on promises that both companies will divest parts of their existing business.
People with heart failure have been found to have less gut bacteria diversity and lack certain important species groups. So are changes in our microbiome causing heart disease, or visa-versa?
